Amicus Therapeutics Inc
FOLD6.320USD
0.000
交易中 （美東）報價延遲15分鐘
1.95B總市值
虧損本益比TTM
關於 Amicus Therapeutics Inc 公司
Amicus Therapeutics, Inc. 是一家生物技術公司，專注於發現、開發和提供治療罕見疾病的新型藥物。其上市的兩種療法是 Galafold，這是第一種針對具有易受治療基因變異的法布里病患者的口服單藥療法，以及 Pombiliti + Opfolda，這是一種新型療法，旨在提高活性酶進入關鍵疾病相關組織的吸收，適用於患有晚髮型龐貝病的成年人。作爲一種口服單藥療法，Galafold 旨在結合並穩定內源性 α-半乳糖苷酶 A (alpha-Gal A) 酶，適用於那些在良好實驗室規範 (GLP) 細胞易受治療性測定中被確定爲易受治療的基因變異的患者。Pombiliti + Opfolda 由獨特設計的 rhGAA 酶 cipaglucosidase alfa-atga 組成，具有優化的碳水化合物結構以增強溶酶體的吸收，與作爲酶穩定劑的 miglustat 聯合使用。
公司簡介
公司代碼FOLD
公司名稱Amicus Therapeutics Inc
上市日期May 31, 2007
CEOMr. Bradley Lewis Campbell
員工數量499
證券類型Ordinary Share
年結日May 31
公司地址47 Hulfish Street
城市PRINCETON
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編08542
電話16096622000
網址https://www.amicusrx.com/
公司代碼FOLD
上市日期May 31, 2007
CEOMr. Bradley Lewis Campbell
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Bradley Lewis Campbell
Mr. Bradley Lewis Campbell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.74K
-14.67%
Ms. Ellen S. Rosenberg, J.D.
Ms. Ellen S. Rosenberg, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
263.90K
-16.12%
Mr. Glenn P. Sblendorio
Mr. Glenn P. Sblendorio
Independent Director
Independent Director
142.56K
+16.71%
Mr. Burke W. Whitman
Mr. Burke W. Whitman
Independent Director
Independent Director
118.60K
+20.79%
Mr. Michael G. (Mike) Raab
Mr. Michael G. (Mike) Raab
Independent Chairman of the Board
Independent Chairman of the Board
115.86K
+21.39%
Mr. Craig A. Wheeler
Mr. Craig A. Wheeler
Independent Director
Independent Director
84.63K
+31.79%
Dr. Adm. Eiry Wyn Roberts, M.D.
Dr. Adm. Eiry Wyn Roberts, M.D.
Independent Director
Independent Director
76.28K
+36.54%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
58.62K
+53.43%
Ms. Margaret G. (Margie) Mcglynn
Ms. Margaret G. (Margie) Mcglynn
Independent Director
Independent Director
51.41K
+65.85%
Mr. David M. Clark
Mr. David M. Clark
Chief People Officer
Chief People Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Bradley Lewis Campbell
Mr. Bradley Lewis Campbell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
615.74K
-14.67%
Ms. Ellen S. Rosenberg, J.D.
Ms. Ellen S. Rosenberg, J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
263.90K
-16.12%
Mr. Glenn P. Sblendorio
Mr. Glenn P. Sblendorio
Independent Director
Independent Director
142.56K
+16.71%
Mr. Burke W. Whitman
Mr. Burke W. Whitman
Independent Director
Independent Director
118.60K
+20.79%
Mr. Michael G. (Mike) Raab
Mr. Michael G. (Mike) Raab
Independent Chairman of the Board
Independent Chairman of the Board
115.86K
+21.39%
Mr. Craig A. Wheeler
Mr. Craig A. Wheeler
Independent Director
Independent Director
84.63K
+31.79%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
Ex U.S
75.26M
60.09%
U.S
49.99M
39.91%
業務
地區
暫無數據
股東統計
更新時間: 7月12日 週六
更新時間: 7月12日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Wellington Management Company, LLP
9.47%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
7.44%
Perceptive Advisors LLC
6.96%
Avoro Capital Advisors LLC
6.65%
Other
60.07%
持股股東
持股股東
佔比
Wellington Management Company, LLP
9.47%
The Vanguard Group, Inc.
9.41%
BlackRock Institutional Trust Company, N.A.
7.44%
Perceptive Advisors LLC
6.96%
Avoro Capital Advisors LLC
6.65%
Other
60.07%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
42.68%
Investment Advisor
33.18%
Hedge Fund
14.01%
Private Equity
7.71%
Research Firm
2.46%
Venture Capital
1.33%
Sovereign Wealth Fund
1.00%
Individual Investor
0.73%
Pension Fund
0.51%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
567
320.58M
104.11%
-8.58M
2025Q1
580
319.34M
103.72%
-10.57M
2024Q4
567
310.09M
100.94%
-22.03M
2024Q3
561
314.37M
105.97%
-28.88M
2024Q2
548
321.61M
108.47%
-24.67M
2024Q1
539
326.71M
110.33%
-17.16M
2023Q4
531
325.44M
110.85%
+1.80M
2023Q3
528
306.18M
105.38%
-26.39M
2023Q2
525
315.35M
109.92%
-11.37M
2023Q1
540
305.58M
107.88%
-22.44M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wellington Management Company, LLP
29.20M
9.48%
+738.62K
+2.60%
Mar 31, 2025
The Vanguard Group, Inc.
29.00M
9.42%
-208.34K
-0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
22.92M
7.44%
-218.69K
-0.95%
Mar 31, 2025
Perceptive Advisors LLC
21.46M
6.97%
-2.78M
-11.47%
Mar 31, 2025
Avoro Capital Advisors LLC
20.50M
6.66%
-2.67M
-11.54%
Mar 31, 2025
William Blair Investment Management, LLC
14.78M
4.8%
-819.05K
-5.25%
Mar 31, 2025
Redmile Group, LLC
9.53M
3.1%
+2.48M
+35.14%
Mar 31, 2025
State Street Global Advisors (US)
9.52M
3.09%
-842.21K
-8.13%
Mar 31, 2025
Citadel Advisors LLC
7.84M
2.55%
-400.41K
-4.86%
Mar 31, 2025
Palo Alto Investors LP
7.35M
2.39%
-317.48K
-4.14%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco Biotechnology & Genome ETF
2.44%
Virtus LifeSci Biotech Products ETF
1.79%
ALPS Medical Breakthroughs ETF
1.19%
Global X Guru Index ETF
1.08%
WisdomTree BioRevolution Fund
1.06%
SPDR S&P Biotech ETF
0.6%
First Trust Innovation Leaders ETF
0.45%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Direxion Daily S&P Biotech Bull 3X Shares
0.34%
JPMorgan Fundamental Data Science Small Core ETF
0.3%
查看更多
Invesco Biotechnology & Genome ETF
佔比2.44%
Virtus LifeSci Biotech Products ETF
佔比1.79%
ALPS Medical Breakthroughs ETF
佔比1.19%
Global X Guru Index ETF
佔比1.08%
WisdomTree BioRevolution Fund
佔比1.06%
SPDR S&P Biotech ETF
佔比0.6%
First Trust Innovation Leaders ETF
佔比0.45%
Invesco NASDAQ Future Gen 200 ETF
佔比0.43%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.34%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.3%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
